Target intelligence / Profile preview

Novel transcript, antisense to QKI (ENSG00000304230)

Target
ENSG00000304230
Molecular classification
Other (natural antisense transcript), long non-coding RNA
01

Overview

ENSG00000304230 encodes a natural antisense transcript overlapping with the QKI gene locus, likely functioning as a regulator of QKI mRNA expression through cis- or trans-acting mechanisms. Antisense transcripts are widespread in mammalian genomes and often modulate gene expression through diverse methods such as altering chromatin structure, RNA stability, splicing, and possibly gene silencing[3][7]. However, ENSG00000304230 itself has not been functionally characterized or linked to specific biological processes or disease contexts. Unlike protein-coding targets, natural antisense transcripts generally lack established molecular classification in reference databases and are actively under investigation as potential regulatory elements and, in some cases, experimental drug targets[1][5][7]. ENSG00000304230 is a transcript annotation rather than a canonical gene/protein target. Its role is likely regulatory, affecting the expression or function of QKI, an RNA-binding protein involved in cell differentiation and RNA metabolism[2][4][6]. Although natural antisense RNAs can play important regulatory and sometimes disease-related roles, ENSG00000304230 does not meet current criteria for structured therapeutic targeting or biomarker applications.

02

Biological functions

Regulation of gene expression (potentially via RNA–RNA interaction, chromatin remodeling, or affecting sense transcript splicing/levels)Possible epigenetic modulation (as seen with disease-relevant antisense RNAs)

Beyond the preview

Go deeper on Novel transcript, antisense to QKI (ENSG00000304230).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to QKI (ENSG00000304230).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call